Shiny new Perle

With the SEC rules on crowd-funding set to take effect on Sept. 23, Perle BioScience Inc. has launched a bid to raise $2 million via that process. The Type I diabetes company hopes the money will be the only private round it needs to reach a liquidity event within two years.

Based on her experience with the last company she co-founded, CureDM Inc., founder Claresa Levetan wanted to eschew the typical VC route in favor of crowd-funding...